Fig. 1From: A validated cellular biobank for β-thalassemia a Distribution of genotypes among consented patients affected by β-thalassemia and sickle-cell anemia (SCA) within the cellular Thal-Biobank. b Number of patients, related genotype and number of vials cryopreserved. c Distribution (expressed as percentage) of the XmnI (rs7482144 −/+), BCL11A (rs1427407 G/T, rs10189857 A/G) and MYB (rs9399137 C/T) polymorphismsBack to article page